🇮🇳India
दावा इनकार प्रबंधन में देरी
2 verified sources
Definition
Denied claims require manual root cause analysis, corrections, and appeals, leading to extended A/R cycles and cash flow delays specific to healthcare RCM in India.
Key Findings
- Financial Impact: ₹10-20 lakhs/month in delayed reimbursements; 30-45 days A/R extension per unresolved claim
- Frequency: Ongoing per denied claim (common 20-30% denial rates)
- Root Cause: Manual handling of denials due to coding errors, documentation gaps, and payer-specific rules
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Medical and Diagnostic Laboratories.
Affected Stakeholders
Billing Manager, Revenue Cycle Team, AR Specialist
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
अपील विफलता से राजस्व हानि
5-15% of total billings lost; 30% unrecovered denial value (₹5-15 lakhs/month for mid-size labs)
इनकार अपील पर कर्मचारी क्षमता हानि
40+ hours/month per staff on rework; ₹2-4 lakhs/month labor cost for 5-person team (₹500/hr loaded rate)
अनबिल्ड लैब सर्विसेज
₹10–30 lakhs annually for mid-sized labs; ₹1.44 lakh/year from one unbilled ₹600 test weekly[2][3]
फर्जी रिपोर्ट फाइन
₹5 lakhs yearly from uncollected charges due to compliance breaches; 1-5% total revenue leakage[1][3][7]
ओवरचार्जिंग पेनल्टी
2-5% revenue leakage from pricing errors and fines; wide cost disparities across cities[1][7]
रिक्विजिशन मैनुअल डिले से आइडल इक्विपमेंट
20-30% equipment idle time; ₹50,000-2 lakh/month lost revenue per analyzer